Exelixis
EXEL
#1696
Rank
A$15.67 B
Marketcap
$54.89
Share price
-3.83%
Change (1 day)
57.54%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: A$15.67 Billion

As of December 2024 Exelixis has a market cap of A$15.67 Billion. This makes Exelixis the world's 1696th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024A$15.67 B43.15%
2023A$10.95 B44.02%
2022A$7.60 B-4.7%
2021A$7.97 B-1.48%
2020A$8.09 B5.9%
2019A$7.64 B-8.67%
2018A$8.37 B-27.32%
2017A$11.52 B92.1%
2016A$5.99 B239.79%
2015A$1.76 B412.03%
2014A$0.34 B-72.82%
2013A$1.26 B56.99%
2012A$0.80 B29.04%
2011A$0.62 B-29.13%
2010A$0.88 B-0.23%
2009A$0.88 B17.84%
2008A$0.75 B-27.33%
2007A$1.03 B-5.66%
2006A$1.09 B2.06%
2005A$1.07 B16.63%
2004A$0.92 B36.15%
2003A$0.67 B-19.81%
2002A$0.84 B-53.88%
2001A$1.82 B49.59%
2000A$1.22 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Exelixis was reported to be:

A$15.67 Billion
by Nasdaq info icon info icon
A$15.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$110.50 B 604.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$194.15 B 1,138.57%๐Ÿ‡ซ๐Ÿ‡ท France
A$400.50 B 2,454.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$185.01 B 1,080.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$226.20 B 1,343.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$557.76 B 3,458.18%๐Ÿ‡บ๐Ÿ‡ธ USA
A$236.99 B 1,411.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$46.22 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.82 B-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA